SPOTLIGHT: Merck not waiting on FDA
The FDA hasn't issued a decision on Merck's Gardasil to protect women from cervical cancer, but the drug maker has already begun an ad campaign aimed at generating some consumer buzz for the therapy. Report
The FDA hasn't issued a decision on Merck's Gardasil to protect women from cervical cancer, but the drug maker has already begun an ad campaign aimed at generating some consumer buzz for the therapy. Report
SHARE
WITH: